Chao Christina K, Sibley Eric
Department of Pediatrics, Stanford University Medical Center, Stanford, CA 94305, USA.
Genet Test. 2004 Summer;8(2):190-3. doi: 10.1089/gte.2004.8.190.
The majority of the world's human population experiences a decline of lactase gene expression during maturation, so-called lactase nonpersistence. Thus, adults with lactase nonpersistence are susceptible to developing symptoms of lactose intolerance. By contrast, lactase persistence is an autosomal dominant heritable condition that results in a high level of lactase gene expression throughout adulthood and sustained lactose tolerance. Lactase persistence has recently been correlated with a single nucleotide genetic variant (a C --> T mutation) located 13,910 bases upstream from the lactase structural gene. We aimed to develop a restriction fragment length polymorphism (RFLP) method of detecting the C/T variants as a means of identifying individuals genetically inclined toward lactase persistence or nonpersistence. Genomic DNA in a 210-bp region surrounding the -13,910-bp variant site was PCR amplified with unique primers designed to avoid or mutate adjacent restriction sites. The amplified DNA was digested with a restriction enzyme, CviJI, that recognizes the base pair sequence generated by the lactase nonpersistence variant. Restriction digest gel analysis yielded DNA fragments of the expected diagnostic molecular weight sizes for individuals that were homozygote or heterozygote for the lactase persistence and nonpersistence variants. The genotypes predicted by the RFLP-based method were confirmed by DNA sequence analysis. The RFLP-based method provides a quick and noninvasive means of molecular detection of the presence or absence of the lactase persistence variant.
世界上大多数人口在成长过程中乳糖酶基因表达会下降,即所谓的乳糖酶不持续性。因此,乳糖酶不持续性的成年人易出现乳糖不耐受症状。相比之下,乳糖酶持续性是一种常染色体显性遗传状况,会导致成年期乳糖酶基因高水平表达并持续具备乳糖耐受性。乳糖酶持续性最近与乳糖酶结构基因上游13,910个碱基处的一个单核苷酸基因变异(C→T突变)相关。我们旨在开发一种检测C/T变异的限制性片段长度多态性(RFLP)方法,作为识别在基因上倾向于乳糖酶持续性或不持续性个体的手段。围绕-13,910碱基变异位点的210碱基对区域内的基因组DNA,用设计好的独特引物进行PCR扩增,以避免或突变相邻的限制性位点。扩增后的DNA用一种限制性内切酶CviJI消化,该酶可识别由乳糖酶不持续性变异产生的碱基对序列。限制性消化凝胶分析产生了预期诊断分子量大小的DNA片段,这些个体为乳糖酶持续性和不持续性变异的纯合子或杂合子。基于RFLP的方法预测的基因型通过DNA序列分析得到了证实。基于RFLP的方法提供了一种快速且非侵入性的分子检测手段,可检测乳糖酶持续性变异的有无。